Patrick McHale
@mchalepatrick.bsky.social
Doctor of Occupational Therapy from Fairfax, VA
#SensoryIntegration #NeuroRehab #GreenspanFloortime #FunctionalAnatomy
#SensoryIntegration #NeuroRehab #GreenspanFloortime #FunctionalAnatomy
Reposted by Patrick McHale
FDA grants Vertex dual approvals: new CF drug Alyftrek for patients 6+ and a Trikafta expansion covering 94 more mutations.
Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings
The FDA on Friday issued two simultaneous cystic fibrosis approvals for Vertex Pharmaceuticals, but included boxed safety warnings for both.
endpts.com
December 23, 2024 at 3:43 PM
FDA grants Vertex dual approvals: new CF drug Alyftrek for patients 6+ and a Trikafta expansion covering 94 more mutations.
Reposted by Patrick McHale
For #FluorescenceFriday, tau (cyan) is shown along with microtubules in primary hippocampal neurons 🔬 #neuroscience #microscopy
December 20, 2024 at 4:40 PM
For #FluorescenceFriday, tau (cyan) is shown along with microtubules in primary hippocampal neurons 🔬 #neuroscience #microscopy
Reposted by Patrick McHale
THE NEURONAL ARCHITECTURE OF AUTONOMIC DYSREFLEXIA https://www.biorxiv.org/content/10.1101/2024.05.06.592781v1
THE NEURONAL ARCHITECTURE OF AUTONOMIC DYSREFLEXIA https://www.biorxiv.org/content/10.1101/2024.05.06.592781v1
Autonomic dysreflexia is a life-threatening medical condition characterized by episodes of uncontrol
www.biorxiv.org
May 9, 2024 at 2:16 AM
THE NEURONAL ARCHITECTURE OF AUTONOMIC DYSREFLEXIA https://www.biorxiv.org/content/10.1101/2024.05.06.592781v1